WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006089678) ANTIBODIES AND PEPTIDES BINDING TO HIV TAT, AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/089678    International Application No.:    PCT/EP2006/001404
Publication Date: 31.08.2006 International Filing Date: 13.02.2006
IPC:
C07K 16/10 (2006.01), A61K 39/12 (2006.01)
Applicants: BIOINVENT INTERNATIONAL AB [SE/SE]; Sölvegatan 41, S-223 70 Lund (SE) (For All Designated States Except US).
CARLSSON, Roland [SE/SE]; (SE) (For US Only).
STENBERG, Yvonne [SE/SE]; (SE) (For US Only).
SONESSON, Elisabeth [SE/SE]; (SE) (For US Only).
GOLDSTEIN, Gideon [US/US]; (US) (For US Only)
Inventors: CARLSSON, Roland; (SE).
STENBERG, Yvonne; (SE).
SONESSON, Elisabeth; (SE).
GOLDSTEIN, Gideon; (US)
Agent: THOMAS, Philip; Eric Potter Clarkson, Park View House, 58 The Ropewalk, Nottingham NG1 5DD (GB)
Priority Data:
60/655,581 22.02.2005 US
Title (EN) ANTIBODIES AND PEPTIDES BINDING TO HIV TAT, AND USES THEREOF
(FR) PEPTIDES ET UTILISATIONS DE CEUX-CI
Abstract: front page image
(EN)The present invention relates to an immunoglobulin variable domain comprising all or a fragment or variant of each of peptide sequences SEQ ID No 2,3 and 4. Generally the invention relates to compositions useful for assaying or treating human immunodeficiency virus- 1(HIV-I) infection. There is also provided antibodies and polypeptides comprising immunoglobulin variable domains, polynucleotides, vectors, host cells encoding immunoglobulin variable domains, pharmaceutical compositions comprising and uses of immunoglobulin variable domains.
(FR)L'invention concerne un domaine variable d'immunoglobuline comprenant la totalité ou un fragment, ou un variant de chacune des séquences peptidiques SEQ ID No 2,3 et 4. De manière générale, cette invention se rapporte à des compositions servant à la détection ou au traitement de l'infection par le virus de 1(VIH-I). L'invention concerne également des anticorps et des polypeptides comprenant des domaines variables d'immunoglobuline, des polynucléotides, des vecteurs, des cellules hôtes codant pour des domaines variables d'immunoglobuline, des compositions pharmaceutiques comprenant ces domaines variables d'immunoglobuline, et les utilisations de ces domaines variables d'immunoglobuline.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)